Northeast Pharmaceutical Group Co Ltd (000597) — Cash Flow-to-Debt Ratio
Northeast Pharmaceutical Group Co Ltd (000597) has a Cash Flow-to-Debt Ratio of 0.03x as of September 2025, meaning its operating cash flow of CN¥274.09 Million could theoretically repay 0% of its total liabilities (CN¥8.05 Billion) in one year. See 000597 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Northeast Pharmaceutical Group Co Ltd Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Northeast Pharmaceutical Group Co Ltd across 28 annual periods. Also explore Northeast Pharmaceutical Group Co Ltd (000597) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Northeast Pharmaceutical Group Co Ltd (1998–2025)
Year-by-year debt coverage analysis for Northeast Pharmaceutical Group Co Ltd. For market capitalisation and broader financial context, see 000597 stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.15x | CN¥1.11 Billion | CN¥7.22 Billion | ▲ +79.3% |
| 2024 | 0.09x | CN¥758.76 Million | CN¥8.88 Billion | ▲ +47.4% |
| 2023 | 0.06x | CN¥586.75 Million | CN¥10.11 Billion | ▼ -52.4% |
| 2022 | 0.12x | CN¥1.11 Billion | CN¥9.10 Billion | ▲ +45.1% |
| 2021 | 0.08x | CN¥746.51 Million | CN¥8.89 Billion | ▲ +18.3% |
| 2020 | 0.07x | CN¥570.92 Million | CN¥8.04 Billion | ▲ +73.6% |
| 2019 | 0.04x | CN¥352.60 Million | CN¥8.62 Billion | ▲ +16.6% |
| 2018 | 0.04x | CN¥285.09 Million | CN¥8.13 Billion | ▲ +193.7% |
| 2017 | -0.04x | CN¥-301.20 Million | CN¥8.05 Billion | ▼ -171.6% |
| 2016 | 0.05x | CN¥384.51 Million | CN¥7.36 Billion | ▲ +229.9% |
| 2015 | 0.02x | CN¥99.70 Million | CN¥6.29 Billion | ▲ +96.0% |
| 2014 | 0.01x | CN¥46.99 Million | CN¥5.81 Billion | ▲ +118.1% |
| 2013 | -0.04x | CN¥-266.38 Million | CN¥5.96 Billion | ▼ -320.4% |
| 2012 | 0.02x | CN¥86.09 Million | CN¥4.24 Billion | ▲ +135.9% |
| 2011 | -0.06x | CN¥-233.32 Million | CN¥4.13 Billion | ▼ -178.1% |
| 2010 | 0.07x | CN¥255.96 Million | CN¥3.54 Billion | ▼ -52.7% |
| 2009 | 0.15x | CN¥615.91 Million | CN¥4.03 Billion | ▼ -45.4% |
| 2008 | 0.28x | CN¥709.03 Million | CN¥2.53 Billion | ▲ +205.2% |
| 2007 | 0.09x | CN¥198.56 Million | CN¥2.16 Billion | ▲ +210.9% |
| 2006 | -0.08x | CN¥-106.00 Million | CN¥1.28 Billion | ▼ -203.9% |
| 2005 | 0.08x | CN¥111.40 Million | CN¥1.40 Billion | ▼ -41.5% |
| 2004 | 0.14x | CN¥211.06 Million | CN¥1.55 Billion | ▼ -2.3% |
| 2003 | 0.14x | CN¥230.08 Million | CN¥1.65 Billion | ▲ +60.0% |
| 2002 | 0.09x | CN¥157.41 Million | CN¥1.81 Billion | ▲ +106.8% |
| 2001 | 0.04x | CN¥78.84 Million | CN¥1.87 Billion | ▲ +105.6% |
| 2000 | 0.02x | CN¥36.13 Million | CN¥1.76 Billion | ▼ -35.1% |
| 1999 | 0.03x | CN¥54.62 Million | CN¥1.73 Billion | ▲ +760.8% |
| 1998 | 0.00x | CN¥-7.59 Million | CN¥1.59 Billion | — |